What top creators are saying about Palantir Technologies Inc.(PLTR)— Page 27

Signed a $100 million, 5-year contract to co-develop a Nuclear Operating System, positioning it as a potential de facto OS for the entire nuclear energy industry, a future trillion-dollar sector.

Very bullish outlook as the stock breaks out to new all-time highs. A potential long-term catalyst is increased NATO defense spending, which could lead to more business for the company.

The chart is described as 'constructive' and in a bullish 'high and tight' pattern, suggesting a potential move to $155. A breakout above the $145 all-time high could signal the next major move higher.

Mentioned as a holding within the hosts' AI-focused portfolios, without specific positive or negative commentary.

Despite a high or 'frothy' valuation, it is considered a 'one-of-one differentiated company' with real 40% growth, making it a favorite among retail investors.

A host sold shares to fund a large purchase, but this was framed as taking profits for a real-life benefit, not as a bearish call on the stock's future.

Potentially benefits from the growing market for AI applications in defense, as suggested by the large government contract awarded to OpenAI.

Potential inclusion in the S&P 500 is viewed as a significant catalyst that could positively impact the stock's performance, valuation, and future trajectory.

Has joined the S&P 500 index, which could lead to increased institutional investment and potentially positive price action.

The author is waiting for a deeper dip before buying, suggesting a cautious stance and that the current price is not a strong entry point.

Showing strong upward momentum and a significant recent surge, suggesting potential continued growth and a short-term bullish signal.

The user's bio mentions $PLTR, suggesting they may provide insights on Palantir Technologies in future posts, though the current post is not actionable.

The user is bullish on PLTR as a 'third-order derivative software company' that will benefit from the broader AI hardware buildout. The stock was up 2% at the time of the post.

Recent price target upgrades to $29-$31, supported by strong AI adoption trends and positive sentiment around its AIP platform.

A fall in the NHS waiting list is viewed as a positive indicator of the company's operational effectiveness and real-world impact due to its involvement with the NHS, signaling positive momentum.